» Articles » PMID: 38816852

Impact of Remote Ischemic Postconditioning on Acute Ischemic Stroke in China: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview
Journal Syst Rev
Publisher Biomed Central
Date 2024 May 30
PMID 38816852
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Acute ischemic stroke (AIS) is a significant health burden in China, affecting a sizable portion of the population. Conventional pharmacological treatments frequently fall short of desirable outcomes. Therefore, exploring alternative therapies is crucial. Remote ischemic postconditioning (RIPostC) is a noninvasive and cost-effective adjunctive therapy. This study aimed to investigate the efficacy and safety of RIPostC as an adjunctive therapy for AIS to inform clinical practice.

Methods: A comprehensive search was conducted across the PubMed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), WanFang, Weipu (VIP), and China Biology Medicine disc (CBM) databases up to October 2023. All included studies underwent bias risk assessment using the Cochrane risk-of-bias assessment tool. The primary outcome measure was the National Institute of Health Stroke Scale (NIHSS), with secondary outcomes including the Barthel index (BI), D-dimer, C-reactive protein (CRP), fibrinogen (FIB), brain-derived neurotrophic factor (BDNF), modified Rankin scale (mRS), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) levels. The data were analyzed using fixed-effects and random-effects models in Review Manager, with mean differences (MDs) and 95% confidence intervals (CIs) calculated for each outcome. The grading of recommendations, assessment, development, and evaluations (GRADE) approach was used to evaluate the level of evidence for each outcome measure.

Results: This meta-analysis included 38 studies, encompassing 4334 patients. Compared with the control group, the RIPostC group had significantly lower NIHSS scores, serum CRP, D-dimer, IL-6, TNF-α, and FIB levels, and increased BDNF levels. Moreover, it improved the patient's BI and mRS scores. According to the GRADE approach, the quality of evidence for mRS was deemed "moderate," while the NIHSS, BI, and CRP were rated as "low" quality. IL-6, TNF-α, FIB, D-dimer, and BDNF received "very low" quality ratings.

Conclusion: The findings suggest that RIPostC activates endogenous protective mechanisms, providing benefits to patients with AIS.

References
1.
Elkind M, Luna J, McClure L, Zhang Y, Coffey C, Roldan A . C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. Stroke. 2014; 45(3):707-16. PMC: 4114338. DOI: 10.1161/STROKEAHA.113.004562. View

2.
Liu Z, Chen C, Li X, Ran Y, Xu T, Zhang Y . Remote Ischemic Preconditioning-Mediated Neuroprotection against Stroke is Associated with Significant Alterations in Peripheral Immune Responses. CNS Neurosci Ther. 2015; 22(1):43-52. PMC: 6492849. DOI: 10.1111/cns.12448. View

3.
Yu H, Ma X, Ma X, Chen M, Chu Y, Wu L . Remote Limb Ischemic Postconditioning Protects Against Ischemic Stroke by Promoting Regulatory T Cells Thriving. J Am Heart Assoc. 2021; 10(22):e023077. PMC: 8751947. DOI: 10.1161/JAHA.121.023077. View

4.
Li J, Zhao X, Meng X, Lin J, Liu L, Wang C . High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial. Stroke. 2016; 47(8):2025-30. DOI: 10.1161/STROKEAHA.116.012901. View

5.
Vinciguerra A, Cepparulo P, Anzilotti S, Cuomo O, Valsecchi V, Amoroso S . Remote postconditioning ameliorates stroke damage by preventing let-7a and miR-143 up-regulation. Theranostics. 2020; 10(26):12174-12188. PMC: 7667695. DOI: 10.7150/thno.48135. View